Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (12396)	12/6/1999 11:32:00 AM
From: aknahow	Respond to of 17367

If you get a fax with information from the "Psoriasis" meeting please post some of the information. I will get hard copies but probably in a day or so.

To: Bluegreen who wrote (12396)	12/6/1999 8:45:00 PM
From: aknahow	Respond to of 17367

IMPORTANT FAQ CHANGES!!!! NEUPREX©: Meningococcemia update 12/6/99 Have you submitted your meningococcemia analysis to the FDA yet? (12/99) Yes. Has the FDA scheduled a meeting? (12/99) Yes. Could you give the meeting date? (12/99) No. Any given date may be subject to unexpected changes, and we want to limit speculation around a particular date. Once we have met with the Agency and made a decision we will announce our next regulatory action. Once you apply for approval, how long will it take the FDA to review? (12/99) We have already requested priority review (a ?fast track? designation) based on the fact that this is a rare and often fatal disease that primarily affects children. If this is granted, the review process is usually completed within 6 months of acceptance of the complete filing. >>>>>>> NOTE THERE ARE OTHER CHANGES. GO TO THE SITE! Note earlier today on Yahoo a post was made indicating Web site changes. If these are what were referred to I did not see them until now.